Post-marketing surveillance of AMYViD Injectio
Not Applicable
Recruiting
- Conditions
- Visualization of amyloid beta plaque in the brain of patients with cognitive dysfunction suspected o
- Registration Number
- JPRN-jRCT2031220067
- Lead Sponsor
- Kazunori Bando
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 500
Inclusion Criteria
Patients who received AMYViD Injection during the enrollment period of this study.
Exclusion Criteria
Patients who enrolled in other clinical studies or clinical trials during the enrollment period of this study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Collect adverse events of AMYViD and confirm its safety.<br> - Unknown adverse drug reactions (particularly important adverse drug reactions) <br> - Factors that may affect safety, efficacy, etc. <br> - Status of adverse drug reactions under actual use of drugs
- Secondary Outcome Measures
Name Time Method